Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Net Margin (2017 - 2025)

Catheter Precision (VTAK) has disclosed Net Margin for 8 consecutive years, with 261.95% as the latest value for Q3 2025.

  • On a quarterly basis, Net Margin rose 402972.0% to 261.95% in Q3 2025 year-over-year; TTM through Sep 2025 was 3319.04%, a 39072.0% decrease, with the full-year FY2024 number at 5190.71%, up 1095680.0% from a year prior.
  • Net Margin was 261.95% for Q3 2025 at Catheter Precision, up from 3812.26% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 61600.0% in Q3 2021 to a low of 168960.0% in Q2 2022.
  • A 5-year average of 16852.32% and a median of 3334.97% in 2025 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: plummeted -16843771bps in 2022, then skyrocketed 16731833bps in 2023.
  • Catheter Precision's Net Margin stood at 834.98% in 2021, then crashed by -20335bps to 168960.0% in 2022, then surged by 100bps to 522.66% in 2023, then crashed by -1285bps to 7238.93% in 2024, then soared by 96bps to 261.95% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Net Margin are 261.95% (Q3 2025), 3812.26% (Q2 2025), and 3334.97% (Q1 2025).